CAPTOPRIL AND HYDROCHLOROTHIAZIDE

Cosette Pharmaceuticals changed its applicant name on NDA 074827 for Captopril and Hydrochlorothiazide from "Cosette" to "Cosette Pharms NC."

Cosette Pharmaceuticals updated the applicant name for Captopril and Hydrochlorothiazide (NDA 074827) from "Cosette" to "Cosette Pharms NC" in FDA records.

Cosette Pharmaceuticals, Inc. updated its applicant name to Cosette Pharms NC for the captopril and hydrochlorothiazide combination product (NDA 074827).

Cosette Pharmaceuticals updated its applicant name from "Cosette" to "Cosette Pharms NC" for the captopril and hydrochlorothiazide combination product (NDA 074827).

Cosette Pharmaceuticals Inc changed its legal entity name to Cosette Pharmaceuticals NC Laboratories LLC for the Captopril and Hydrochlorothiazide combination product (NDA 074827).

Cosette Pharmaceuticals NC Laboratories LLC is now listed as the applicant for the captopril and hydrochlorothiazide combination product (NDA 074827).

Cosette Pharmaceuticals changed its legal entity name from Cosette Pharmaceuticals Inc to Cosette Pharmaceuticals NC Laboratories LLC for the Captopril and Hydrochlorothiazide combination product (NDA 074827).

Cosette Pharmaceuticals Inc changed its legal entity name to Cosette Pharmaceuticals NC Laboratories LLC for NDA 074827 (Captopril and Hydrochlorothiazide).